Peptides · Peptide comparison
Fertirelin vs Gonadorelin (GnRH)
A potent GnRH analog designed to support reproductive function in veterinary and research settings
The master hormone that controls your reproductive system and fertility
- Hormone Support
- Hormone Support
At a glance
Quick comparison
Efficacy
Benefit ratings
Reproductive Synchronization
Hormone Support
Veterinary Breeding Enhancement
Reproductive Health
Hormone Balance
Ovulation Support
Technical data
Compound specifications
Fertirelin
- Molecular formula
- C55H76N16O12
- Molecular weight
- 1153.3 g/mol
- Half-life
- Variable depending on formulation; sustained-release formulations extend duration
- Bioavailability
- High when administered via injection
- CAS number
- 66002-66-2
Gonadorelin (GnRH)
- Molecular formula
- C55H75N17O13
- Molecular weight
- 1182.3
- Half-life
- 2-4 minutes
- Bioavailability
- Varies by route: ~5-20% (intranasal), 100% (IV/IM injections)
- CAS number
- 34973-08-5
Protocols
Dosing compared
Fertirelin
Intramuscular
- 50-100 mcg per animalSingle injection at the defined point in the synchronization protocol · Single dose (repeated per breeding cycle as needed)Fertirelin is a veterinary GnRH agonist. In dairy cattle, 50 mcg and 100 mcg intramuscular both triggered an LH surge and comparable conception rates for ovulation synchronization and fixed-time insemination [4]. Used to induce ovulation and improve conception in cattle [1].
Gonadorelin (GnRH)
Subcutaneous
- 100 mcgSingle dose · One-time diagnostic testFDA-labeled gonadotropin (LH/FSH) stimulation test for pituitary reserve; 100 mcg given once subcutaneously (or IV), with LH measured at 0, 15, 30, 45, 60 and 120 minutes (Factrel) [4].
Intravenous
- 5 mcg per pulse (range 1-20 mcg)Every 90 minutes via pulsatile pump · One or more ovulatory cycles; reassessed at 21-day intervalsFDA-labeled pulsatile regimen for ovulation induction in hypothalamic amenorrhea (Lutrepulse); intravenous pulsatile delivery gave better results than subcutaneous [5]. The 2-4 minute half-life makes pulsatile delivery essential.
Applications
Best suited for
Fertirelin
- Livestock breeding programs
- Fertirelin is particularly well-suited for individuals focused on livestock breeding programs. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Reproductive synchronization in cattle
- Fertirelin is particularly well-suited for individuals focused on reproductive synchronization in cattle. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Fertility enhancement in veterinary settings
- Fertirelin is particularly well-suited for individuals focused on fertility enhancement in veterinary settings. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Research on reproductive hormone mechanisms
- Fertirelin is particularly well-suited for individuals focused on research on reproductive hormone mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Gonadorelin (GnRH)
- Improving fertility and conception chances
- Gonadorelin (GnRH) is particularly well-suited for individuals focused on improving fertility and conception chances. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Regulating irregular menstrual cycles
- Gonadorelin (GnRH) is particularly well-suited for individuals focused on regulating irregular menstrual cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Enhancing reproductive hormone levels
- Gonadorelin (GnRH) is particularly well-suited for individuals focused on enhancing reproductive hormone levels. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Supporting natural pregnancy attempts
- Gonadorelin (GnRH) is particularly well-suited for individuals focused on supporting natural pregnancy attempts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Fertirelin
Common
- Mild discomfort at treatment site
- Transient hormone fluctuations
- Temporary behavioral changes in animals
- Mild injection site reactions
- Short-term changes in appetite
- Temporary mood variations
- Minimal systemic effects at therapeutic doses
Uncommon
- Occasional swelling at injection site
Serious
- Severe allergic reaction
Gonadorelin (GnRH)
Common
- Mild headache
- Local injection site reactions (redness, swelling)
- Temporary hot flashes
- Mood changes or emotional sensitivity
- Nausea or mild stomach upset
- Allergic skin reactions
- Dizziness or lightheadedness
- Temporary changes in vision
- Joint or muscle aches
- Insomnia or sleep disturbances
- Severe allergic reactions (difficulty breathing, swelling)
- Severe hormonal imbalance symptoms
- Ovarian hyperstimulation syndrome (OHSS)
- Signs of blood clots (chest pain, leg swelling)
- Severe mood changes or depression
Serious
- Severe allergic reaction
Research status
Safety & evidence
Fertirelin
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Fertirelin is a GnRH agonist developed specifically for veterinary use in livestock, particularly cattle breeding and fertility management. The peptide has been safely used in veterinary medicine for over 40 years with a well-documented safety profile in animals. Important limitation: Fertirelin is NOT approved for human use. All safety and efficacy data comes from veterinary applications in cattle and limited laboratory research. Human safety data is minimal and extrapolation from veterinary use is problematic. The biphasic response (initial hormone surge followed by suppression) must be carefully managed in any application. Individual responses can vary significantly based on age, hormonal status, and concurrent medications.
Contraindications
- Pregnancy (may disrupt existing pregnancy)
- Hypersensitivity to GnRH analogs
- Active reproductive infections
- Concurrent use with certain medications
- Undiagnosed reproductive disorders
Gonadorelin (GnRH)
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Previously FDA approved: FACTREL (1982) as a diagnostic test of pituitary gonadotropin reserve and LUTREPULSE (1989) for ovulation induction. Both human products are discontinued in the US.
- Safety overview
- Gonadorelin is native GnRH and carries the safety profile established over 40+ years of clinical use in reproductive endocrinology. As the body's natural hormone, it produces minimal local side effects when dosed appropriately. The critical safety concern with gonadorelin is the initial flare effect within 24-48 hours of first dose—temporary elevation in FSH and LH—which can paradoxically suppress sex hormones before the desired stimulation occurs. This flare makes gonadorelin unsuitable for some conditions and explains why synthetic analogs (agonists, antagonists) are preferred in many modern fertility protocols.
Contraindications
- Pregnancy or breastfeeding
- Hormone-sensitive cancers (breast, prostate, ovarian)
- Severe pituitary or hypothalamic disease
- Undiagnosed abnormal vaginal bleeding
- Known hypersensitivity to GnRH
Decision guide
Which is right for you?
Fertirelin
Choose Fertirelin if…
- Livestock breeding programs
- Reproductive synchronization in cattle
- Fertility enhancement in veterinary settings
- Research on reproductive hormone mechanisms
Gonadorelin (GnRH)
Choose Gonadorelin (GnRH) if…
- Improving fertility and conception chances
- Regulating irregular menstrual cycles
- Enhancing reproductive hormone levels
- Supporting natural pregnancy attempts